These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16866770)

  • 21. A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment.
    Ertam I; Sezgin AO; Unal I
    Int J Dermatol; 2009 Jan; 48(1):98-9. PubMed ID: 19126064
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: a 30-year observational study.
    Leon AC; Solomon DA; Li C; Fiedorowicz JG; Coryell WH; Endicott J; Keller MB
    Am J Psychiatry; 2012 Mar; 169(3):285-91. PubMed ID: 22193537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticonvulsant hypersensitivity syndrome from addition of lamotrigine to divalproex.
    Rahman M; Haider N
    Am J Psychiatry; 2005 May; 162(5):1021. PubMed ID: 15863816
    [No Abstract]   [Full Text] [Related]  

  • 24. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder.
    Calabrese JR; Bowden CL; McElroy SL; Cookson J; Andersen J; Keck PE; Rhodes L; Bolden-Watson C; Zhou J; Ascher JA
    Am J Psychiatry; 1999 Jul; 156(7):1019-23. PubMed ID: 10401445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somnambulism secondary to olanzapine treatment in one patient with bipolar disorder.
    Chiu YH; Chen CH; Shen WW
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):581-2. PubMed ID: 18006134
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of medication adherence in a cohort of patients with bipolar disorder.
    González-Pinto A; Reed C; Novick D; Bertsch J; Haro JM
    Pharmacopsychiatry; 2010 Nov; 43(7):263-70. PubMed ID: 20842617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
    Redrobe JP; Nielsen AN
    Behav Brain Res; 2009 Mar; 198(2):481-5. PubMed ID: 19162078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. About lamotrigine and its hepatic effects.
    Selek S; Haluk SA
    CNS Spectr; 2005 Jul; 10(7):522; author reply 522. PubMed ID: 16167407
    [No Abstract]   [Full Text] [Related]  

  • 29. Bipolar drug development: are we getting closer to the real world?
    Calabrese JR; Kemp DE
    Am J Psychiatry; 2008 Oct; 165(10):1234-6. PubMed ID: 18829876
    [No Abstract]   [Full Text] [Related]  

  • 30. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.
    Calvert NW; Burch SP; Fu AZ; Reeves P; Thompson TR
    J Manag Care Pharm; 2006 May; 12(4):322-30. PubMed ID: 16792438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An association of intrusive, repetitive phrases with lamotrigine treatment in bipolar II disorder.
    Kemp DE; Gilmer WS; Fleck J; Dago PL
    CNS Spectr; 2007 Feb; 12(2):106-11. PubMed ID: 17277710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two cases of acneiform eruption associated with lamotrigine.
    Nielsen JN; Licht RW; Fogh K
    J Clin Psychiatry; 2004 Dec; 65(12):1720-2. PubMed ID: 15641879
    [No Abstract]   [Full Text] [Related]  

  • 33. [Secondary delirium due to the use of lamotrigine with abrupt increase valproic acid's dose].
    Rocha FF
    Braz J Psychiatry; 2008 Mar; 30(1):88. PubMed ID: 18373026
    [No Abstract]   [Full Text] [Related]  

  • 34. Three medication pathways for bipolar disorder.
    Blake T
    Nursing; 2012 May; 42(5):28-35; quiz 35-6. PubMed ID: 22488206
    [No Abstract]   [Full Text] [Related]  

  • 35. Lamotrigine and bipolar disorder: new indication. Only after lithium, like other antiepileptics. Preventive effects in only one aspect of bipolar disorder, but with a risk of Lyell syndrome.
    Prescrire Int; 2009 Oct; 18(103):201. PubMed ID: 19882784
    [No Abstract]   [Full Text] [Related]  

  • 36. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6).
    Licht RW; Nielsen JN; Gram LF; Vestergaard P; Bendz H
    Bipolar Disord; 2010 Aug; 12(5):483-93. PubMed ID: 20712749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vigency of lithium treatment].
    Vieta E; Cruz N; Sánchez-Moreno J
    Med Clin (Barc); 2007 Jan; 128(1):36; author reply 36-7. PubMed ID: 17266894
    [No Abstract]   [Full Text] [Related]  

  • 38. Adjunctive lamotrigine as a possible mania inducer in bipolar patients.
    Raskin S; Teitelbaum A; Zislin J; Durst R
    Am J Psychiatry; 2006 Jan; 163(1):159-60. PubMed ID: 16390907
    [No Abstract]   [Full Text] [Related]  

  • 39. Lamotrigine in mood disorders.
    Green B
    Curr Med Res Opin; 2003; 19(4):272-7. PubMed ID: 12841919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment of bipolar disorder with lamotrigine.
    Calabrese JR; Shelton MD; Rapport DJ; Kimmel SE; Elhaj O
    J Clin Psychiatry; 2002; 63 Suppl 10():18-22. PubMed ID: 12392349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.